Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention

We aimed to estimate the utility of panel‐based pharmacogenetic testing of patients undergoing percutaneous coronary intervention (PCI). Utilization of Clinical Pharmacogenetic Implementation Consortium (CPIC) level A/B drugs after PCI was estimated in a national sample of IBM MarketScan beneficiari...

Descripción completa

Detalles Bibliográficos
Autores principales: El Rouby, Nihal, Alrwisan, Adel, Langaee, Taimour, Lipori, Gloria, Angiolillo, Dominick J, Franchi, Francesco, Riva, Alberto, Elsey, Amanda, Johnson, Julie A., Cavallari, Larisa H., Winterstein, Almut G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214641/
https://www.ncbi.nlm.nih.gov/pubmed/31758664
http://dx.doi.org/10.1111/cts.12729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214641/
https://www.ncbi.nlm.nih.gov/pubmed/31758664
http://dx.doi.org/10.1111/cts.12729

Ejemplares similares